AKIP1

Across TCGA pan-cancer cohorts, AKIP1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated AKIP1 data layer compared with 28 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher AKIP1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated AKIP1 expression acts as an unfavorable survival marker.

LSCC, GBM, and LUAD are the cancer types where AKIP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	DFS	Quartile	All	0.446	0.902	<.001	12	view →
GBM	DFS	Tertile	All	0.354	0.764	.038	6	view →
LUAD	DFS	Median	All	0.781	0.963	.008	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

AKIP1–LSCC (DFS)

Open the LSCC breakdown →